Responses
Clinical and epidemiological research
Extended report
Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)
Compose a Response to This Article
Other responses
No responses have been published for this article.